• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区中未被发现的痴呆症的患病率及决定因素:一项系统文献综述和荟萃分析。

Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis.

作者信息

Lang Linda, Clifford Angela, Wei Li, Zhang Dongmei, Leung Daryl, Augustine Glenda, Danat Isaac M, Zhou Weiju, Copeland John R, Anstey Kaarin J, Chen Ruoling

机构信息

Faculty of Education, Health and Wellbeing University of Wolverhampton, Wolverhampton, UK.

Post Graduate Academic Institute of Medicine, University of Wolverhampton, Wolverhampton, UK.

出版信息

BMJ Open. 2017 Feb 3;7(2):e011146. doi: 10.1136/bmjopen-2016-011146.

DOI:10.1136/bmjopen-2016-011146
PMID:28159845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5293981/
Abstract

OBJECTIVES

Detection of dementia is essential for improving the lives of patients but the extent of underdetection worldwide and its causes are not known. This study aimed to quantify the prevalence of undetected dementia and to examine its correlates.

METHODS/SETTING/PARTICIPANTS: A systematic search was conducted until October 2016 for studies reporting the proportion of undetected dementia and/or its determinants in either the community or in residential care settings worldwide. Random-effects models calculated the pooled rate of undetected dementia and subgroup analyses were conducted to identify determinants of the variation.

PRIMARY AND SECONDARY OUTCOME MEASURES

The outcome measures of interest were the prevalence and determinants of undetected dementia.

RESULTS

23 studies were eligible for inclusion in this review. The pooled rate of undetected dementia was 61.7% (95% CI 55.0% to 68.0%). The rate of underdetection was higher in China and India (vs Europe and North America), in the community setting (vs residential/nursing care), age of <70 years, male gender and diagnosis by general practitioner. However, it was lower in the studies using Mini-Mental State Examination (MMSE) diagnosis criteria.

CONCLUSIONS

The prevalence of undetected dementia is high globally. Wide variations in detecting dementia need to be urgently examined, particularly in populations with low socioeconomic status. Efforts are required to reduce diagnostic inequality and to improve early diagnosis in the community.

摘要

目的

痴呆症的检测对于改善患者生活至关重要,但全球范围内检测不足的程度及其原因尚不清楚。本研究旨在量化未被检测出的痴呆症的患病率,并探讨其相关因素。

方法/研究背景/参与者:截至2016年10月,我们进行了系统检索,以查找报告全球社区或机构护理环境中未被检测出的痴呆症比例及其决定因素的研究。随机效应模型计算了未被检测出的痴呆症的合并率,并进行了亚组分析以确定变异的决定因素。

主要和次要结局指标

感兴趣的结局指标是未被检测出的痴呆症的患病率及其决定因素。

结果

23项研究符合纳入本综述的条件。未被检测出的痴呆症的合并率为61.7%(95%置信区间55.0%至68.0%)。在中国和印度(与欧洲和北美相比)、社区环境(与机构/护理环境相比)、年龄小于70岁、男性以及由全科医生诊断的情况下,检测不足的比例更高。然而,在使用简易精神状态检查表(MMSE)诊断标准的研究中,该比例较低。

结论

全球范围内未被检测出的痴呆症患病率很高。迫切需要研究痴呆症检测方面的广泛差异,特别是在社会经济地位较低的人群中。需要努力减少诊断不平等现象,并改善社区中的早期诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69df/5293981/22365aff1192/bmjopen2016011146f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69df/5293981/22365aff1192/bmjopen2016011146f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69df/5293981/22365aff1192/bmjopen2016011146f01.jpg

相似文献

1
Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis.社区中未被发现的痴呆症的患病率及决定因素:一项系统文献综述和荟萃分析。
BMJ Open. 2017 Feb 3;7(2):e011146. doi: 10.1136/bmjopen-2016-011146.
2
Reminiscence therapy for dementia.痴呆症的回忆疗法
Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
6
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.
7
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
10
Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care.为长期护理中的痴呆症患者改善心理社会状况而量身定制的活动。
Cochrane Database Syst Rev. 2018 Feb 13;2(2):CD009812. doi: 10.1002/14651858.CD009812.pub2.

引用本文的文献

1
A Real-World Analysis of the Clinical Journey, Diagnosis, and Monitoring Patterns of Patients With Alzheimer Disease by Stage in the United States.美国阿尔茨海默病患者按阶段划分的临床病程、诊断及监测模式的真实世界分析
Am J Alzheimers Dis Other Demen. 2025 Jan-Dec;40:15333175251375378. doi: 10.1177/15333175251375378. Epub 2025 Sep 12.
2
Combinations of multimodal neuroimaging biomarkers and cognitive test scores to identify patients with cognitive impairment.多模态神经影像生物标志物与认知测试分数的组合用于识别认知障碍患者。
Front Aging Neurosci. 2025 Aug 13;17:1650629. doi: 10.3389/fnagi.2025.1650629. eCollection 2025.
3

本文引用的文献

1
Rates of formal diagnosis of dementia in primary care: The effect of screening.初级保健中痴呆症的正式诊断率:筛查的影响。
Alzheimers Dement (Amst). 2015 Mar 29;1(1):87-93. doi: 10.1016/j.dadm.2014.11.007. eCollection 2015 Mar.
2
Who has undiagnosed dementia? A cross-sectional analysis of participants of the Aging, Demographics and Memory Study.谁患有未确诊的痴呆症?对老龄化、人口统计学和记忆研究参与者的横断面分析。
Age Ageing. 2015 Jul;44(4):642-7. doi: 10.1093/ageing/afv020. Epub 2015 Mar 10.
3
Determinants for undetected dementia and late-life depression.
An innovative health systems approach to support early detection of cognitive impairment in primary care - the brain health navigator.
一种创新的卫生系统方法,以支持在初级保健中早期发现认知障碍——脑健康导航员。
BMC Prim Care. 2025 Aug 28;26(1):271. doi: 10.1186/s12875-025-02977-w.
4
Diagnostic test accuracy of screening tools for the detection of neurocognitive disorders in older adults post-trauma in acute care settings: a systematic review.急性护理环境中创伤后老年患者神经认知障碍检测筛查工具的诊断测试准确性:一项系统综述
Eur Geriatr Med. 2025 Aug 18. doi: 10.1007/s41999-025-01287-9.
5
Diagnostic Reversion in Dementia Care: A Real-World Analysis of Mild Cognitive Impairment Diagnoses Following Dementia in a Large Electronic Medical Record System.痴呆症护理中的诊断逆转:大型电子病历系统中痴呆症患者轻度认知障碍诊断的真实世界分析
medRxiv. 2025 Jul 17:2025.07.16.25331678. doi: 10.1101/2025.07.16.25331678.
6
The National Dementia Workforce Study: Methods for Surveying Community Clinicians Who Provide Care to People With Dementia.国家痴呆症劳动力研究:对为痴呆症患者提供护理的社区临床医生进行调查的方法。
J Am Geriatr Soc. 2025 Aug 8. doi: 10.1111/jgs.70037.
7
Real-world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee-for-service beneficiaries.医疗保险按服务收费受益人群中用于轻度认知障碍、阿尔茨海默病及其他痴呆症的诊断测试的实际应用情况。
Alzheimers Dement (Amst). 2025 Aug 4;17(3):e70156. doi: 10.1002/dad2.70156. eCollection 2025 Jul-Sep.
8
Machine Learning-Based Cognitive Assessment With The Autonomous Cognitive Examination: Randomized Controlled Trial.基于机器学习的自主认知检查认知评估:随机对照试验。
J Med Internet Res. 2025 Jul 30;27:e67446. doi: 10.2196/67446.
9
Underdetection of neurocognitive disorders in Southern Italy: Evidence from the Salento region.意大利南部神经认知障碍的漏检:来自萨伦托地区的证据。
J Prev Alzheimers Dis. 2025 Sep;12(8):100295. doi: 10.1016/j.tjpad.2025.100295. Epub 2025 Jul 22.
10
Societal Costs and Efficiency of Subcutaneous versus Intravenous Lecanemab in Early Alzheimer's Disease: A U.S. Cost Comparison Model.皮下注射与静脉注射lecanemab治疗早期阿尔茨海默病的社会成本与效率:美国成本比较模型
Neurol Ther. 2025 Jul 4. doi: 10.1007/s40120-025-00790-2.
未被发现的痴呆症和老年期抑郁症的决定因素。
Br J Psychiatry. 2013 Sep;203(3):203-8. doi: 10.1192/bjp.bp.112.119354. Epub 2013 Jul 25.
4
Prevalence and correlates of potentially undetected dementia among residents of institutional care facilities in Ontario, Canada, 2009-2011.2009-2011 年加拿大安大略省机构护理设施居民中潜在未检出痴呆症的患病率及相关因素。
Int J Geriatr Psychiatry. 2013 Oct;28(10):1086-94. doi: 10.1002/gps.3934. Epub 2013 Feb 4.
5
Estimating the prevalence of dementia: cognitive screening in Glasgow nursing homes.估计痴呆症的患病率:格拉斯哥养老院的认知筛查。
Int J Geriatr Psychiatry. 2012 Aug;27(8):785-91. doi: 10.1002/gps.2784. Epub 2011 Nov 14.
6
A multicentre community-based study of dementia cases and subcases in older people in China--the GMS-AGECAT prevalence and socio-economic correlates.中国老年人痴呆病例和亚病例的多中心社区研究——GMS-AGECAT 患病率及社会经济相关性。
Int J Geriatr Psychiatry. 2012 Jul;27(7):692-702. doi: 10.1002/gps.2767. Epub 2011 Sep 21.
7
Underdiagnosis of dementia in primary care: variations in the observed prevalence and comparisons to the expected prevalence.初级保健中痴呆的漏诊:观察到的患病率的变化及其与预期患病率的比较。
Aging Ment Health. 2011 Nov;15(8):978-84. doi: 10.1080/13607863.2011.596805. Epub 2011 Jul 21.
8
The accuracy of family physicians' dementia diagnoses at different stages of dementia: a systematic review.家庭医生在痴呆不同阶段的痴呆诊断准确性:系统评价。
Int J Geriatr Psychiatry. 2012 Apr;27(4):342-54. doi: 10.1002/gps.2726. Epub 2011 May 30.
9
The 10/66 dementia research group - 10 years on.10/66 痴呆症研究组 - 10 年回顾。
Indian J Psychiatry. 2009 Jan;51 Suppl 1(Suppl1):S8-S15.
10
New diagnoses of dementia among older patients admitted to postacute care.老年患者在接受康复治疗后新诊断出的痴呆症。
J Am Med Dir Assoc. 2010 Jun;11(5):371-6. doi: 10.1016/j.jamda.2009.10.002. Epub 2010 Mar 24.